SCHEMBL5982817

SCHEMBL5982817

OC[C@@H]1O[C@H](n2cnc3c(Br)ncnc32)C[C@H]1O

nearest known ligand 0.75

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 1/20 0.75
▸ PIM1 P11309 1/20 0.63
▸ CSNK2A2 P19784 1/20 0.63
▸ CSNK2B P67870 1/20 0.63
▸ CSNK2A1 P68400 1/20 0.63
▸ CSNK2A3 Q8NEV1 1/20 0.63
▸ PNP P00491 1/20 0.57
▸ LMNA P02545 1/20 0.57
▸ TP53 P04637 1/20 0.57
▸ HTT P42858 1/20 0.57
▸ PDE4D Q08499 1/20 0.57
▸ PDE3A Q14432 1/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ RXFP1 Q9HBX9 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5982824 1.00 HIF1A (0.75) HIF1APIM1CSNK2A2CSNK2BCSNK2A1
Deoxyinosine SCHEMBL24307 0.86 HIF1A (0.73) HIF1APIM1CSNK2A2CSNK2BCSNK2A1
Deoxyinosine SCHEMBL2000526 0.86 HIF1A (0.73) HIF1APIM1CSNK2A2CSNK2BCSNK2A1
Deoxyinosine SCHEMBL324457 0.86 HIF1A (0.73) HIF1APIM1CSNK2A2CSNK2BCSNK2A1
Deoxyinosine SCHEMBL7191121 0.86 HIF1A (0.73) HIF1APIM1CSNK2A2CSNK2BCSNK2A1
Deoxyinosine SCHEMBL29357821 0.86 HIF1A (0.73) HIF1APIM1CSNK2A2CSNK2BCSNK2A1
Deoxyinosine SCHEMBL5982293 0.86 HIF1A (0.73) HIF1APIM1CSNK2A2CSNK2BCSNK2A1
Deoxyadenosine SCHEMBL23982174 0.85 HIF1A (0.71) HIF1APNPLMNATP53HTT
SCHEMBL21563936 0.85 HIF1A (0.71) HIF1APNPLMNATP53HTT
Deoxyadenosine SCHEMBL19877 0.85 HIF1A (0.71) HIF1APNPLMNATP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1634888-A2 Synthesis of 2'-deoxy-L-nucleosides Pharmasset Limited (US) 2006-03-15 — — EP disclosed
EP-1600452-A2 Synthesis of 2'-deoxy-L-nucleosides Pharmasset Limited (US) 2005-11-30 — — EP disclosed
EP-1600451-A2 Synthesis of 2'-deoxy-l-nucleosides Pharmasset Limited (US) 2005-11-30 — — EP disclosed
US-20050090660-A1 2'-deoxy-L-nucleosides PHARMASSET, INC. 2005-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090660-A1 2'-deoxy-L-nucleosides CCNH, ADAR, NSUN2 HIF1A 2249/4885PIM1 3472/4885CSNK2A2 473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback